(Q35643903)

9 August 2017

1 reference

title

Vaccine allergy: diagnosis and management (English)

1 reference

9 August 2017

Arvind Madaan

1

1 reference

9 August 2017

Daniel E Maddox

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Immunology and Allergy Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

23

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

555-588

1 reference

Do parents understand immunizations? A national telephone survey

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Safe administration of the measles vaccine to children allergic to eggs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Safe administration of influenza vaccine to patients with egg allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Clinical and immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

The safety of egg-containing vaccines for egg-allergic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Immediate reactions following live attenuated measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Current issues with influenza vaccination in egg allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Guidelines for measles vaccination in egg-allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Raw egg allergy-a potential issue in vaccine allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Gelatin-containing diphtheria-tetanus-pertussis (DTP) vaccine causes sensitization to gelatin in the recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

IgE-mediated systemic reactions to gelatin included in the varicella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Two patterns of systemic immediate-type reactions to Japanese encephalitis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Urticaria following varicella vaccine associated with gelatin allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Allergic reactions to measles-mumps-rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Change in gelatin content of vaccines associated with reduction in reports of allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

IgE sensitization to gelatin: the probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

1 reference

7 January 2021

Gelatin-induced T-cell activation in children with nonanaphylactic-type reactions to vaccines containing gelatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

The relevance of TH1 and TH2 cells in immediate and nonimmediate reactions to gelatin-containing vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Specific IgG to gelatin in children with systemic immediate- and nonimmediate-type reactions to measles, mumps and rubella vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Sensitization to thimerosal and previous vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Hyposensitizing therapy with standard antigenic extracts: an important source of thimerosal sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Systemic reactions due to thiomersal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Vaccination of children following a previous hypotonic-hyporesponsive episode

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Preventing harm from thimerosal in vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

1 reference

7 January 2021

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Development of a pertussis component vaccine in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

The role of aluminium for adverse reactions and immunogenicity of diphtheria-tetanus booster vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

Repeat whole cell vaccinations should be avoided after hypotonic-hyporesponsive episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900099-7

7 January 2021

10.1016/S0889-8561(03)00099-7

Identifiers

DOI

1 reference

9 August 2017

1 reference